000 | 01939 a2200541 4500 | ||
---|---|---|---|
005 | 20250516042939.0 | ||
264 | 0 | _c20110926 | |
008 | 201109s 0 0 eng d | ||
022 | _a1556-5653 | ||
024 | 7 |
_a10.1016/j.fertnstert.2011.05.063 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOlivares, Carla | |
245 | 0 | 0 |
_aThe inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. _h[electronic resource] |
260 |
_bFertility and sterility _cAug 2011 |
||
300 |
_a428-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCelecoxib |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEndometriosis _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
650 | 0 | 4 |
_aPPAR gamma _xagonists |
650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aRosiglitazone |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUterus _xtransplantation |
700 | 1 | _aRicci, Analía | |
700 | 1 | _aBilotas, Mariela | |
700 | 1 | _aBarañao, Rosa Inés | |
700 | 1 | _aMeresman, Gabriela | |
773 | 0 |
_tFertility and sterility _gvol. 96 _gno. 2 _gp. 428-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.fertnstert.2011.05.063 _zAvailable from publisher's website |
999 |
_c20938432 _d20938432 |